Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 1 Neoplasms, Bone Tissue 1

Interventions

Specimen Handling 111 Magnetic Resonance Spectroscopy 88 Carboplatin 58 pembrolizumab 57 Biopsy 56 Cisplatin 51 Nivolumab 46 Paclitaxel 39 Radiotherapy 38 Cyclophosphamide 38 Gemcitabine 33 Dexamethasone 31 Radiation 30 Bevacizumab 30 atezolizumab 27 Pemetrexed 27 Etoposide 27 olaparib 24 Lenalidomide 24 Doxorubicin 23 X-Rays 22 Vincristine 22 Prednisone 22 Leucovorin 22 Immunoglobulin G 22 Docetaxel 22 Disulfides 22 venetoclax 21 durvalumab 21 Rituximab 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × mifamurtide × 30 days × Clear all

NCT03643133 2026-05-19

SARCOME13

UNICANCER

Phase 2 Active not recruiting

Osteosarcoma, Neoplasms, Bone Tissue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡